Evidence map›Paper›PMID 30099857›Full record

Trial reportCancer medicine2018

Programmed environmental illumination during autologous stem cell transplantation hospitalization for the treatment of multiple myeloma reduces severity of depression: A preliminary randomized controlled trial.

Heiðdís B Valdimarsdottir, Mariana G Figueiro, William Holden, Susan Lutgendorf, Lisa M Wu, Sonia Ancoli-Israel, Jason Chen, Ariella Hoffman-Peterson, Julia Granski, Nina Prescott and 4 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07661966 (A Pilot Trial of Bright Light Therapy in Patients Receiving First Line Immune Checkpoint Blockade), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07661966 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Pilot Trial of Bright Light Therapy in Patients Receiving First Line Immune Checkpoint Blockade

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2026 to 2027Enrolled12ConditionsMelanoma (Skin Cancer), NSCLC (Non-small Cell Lung Cancer)ArmsBright Light Therapy
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Optimizing high dose melphalan.Blood reviews · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Heiðdís B ValdimarsdottirPsychology, Reykjavik University, Reykjavik, Iceland.ORCID 0000-0001-9976-0007
Mariana G FigueiroRensselaer Polytechnic Institute, Troy, New York.
William HoldenPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.ORCID 0000-0002-0498-0005
Susan LutgendorfDepartments of Psychology and Brain Sciences, Obstetrics and Gynecology, and Urology, University of Iowa College of Liberal Arts and Sciences, Iowa City, Iowa.
Lisa M WuDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois.ORCID 0000-0003-2241-9905
Sonia Ancoli-IsraelDepartment of Psychiatry, University of California San Diego, La Jolla, California.
Jason ChenPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
Ariella Hoffman-PetersonPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
Julia GranskiPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
Nina PrescottPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
Alejandro VegaPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
Natalie SternPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
Gary WinkelPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
William H ReddPopulation Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York.
Icahn School of Medicine at Mount Sinai · USNorthwestern University · USRensselaer Polytechnic Institute · USReykjavík University · ISUniversity of California San Diego · USUniversity of Iowa · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Jon C.D. Houtman · 2000 to 2026
$70.0M
Treating cognitive impairments in cancer patients via systematic light exposureK07CA184145 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, LISA MARIA · 2015 to 2019
$835k
Systematic Programmed Illumination (sPI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue During Hematopoeitic Stem Cell Transplantation for Multiple MyelomaR21CA209419 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI REDD, WILLIAM H · 2016 to 2017
$414k
NCI NIH HHS K07 CA184145NCI NIH HHS R21 CA209419
6 · The paper itself

Abstract

backgroundOver a third of multiple myeloma (MM) patients report clinical levels of depression during autologous stem cell transplant (ASCT) hospitalization. We report preliminary results from a randomized clinical trial investigating the effect of Programmed Environmental Illumination (PEI) of hospital rooms on depression.

methodsPatients (N = 187) scheduled to receive an ASCT were assessed for eligibility. Those who met study eligibility criteria (n = 44) were randomly assigned to one of two PEI conditions involving delivery of either circadian active bright white light (BWL) or circadian inactive dim white light (DWL) throughout the room from 7 to 10 am daily during hospitalization. Patients completed the Center for Epidemiological Studies Depression Scale (CES-D) prior to hospitalization, at days 2 and 7 post-transplant, and on the third day of engraftment.

resultsGeneral linear model analyses revealed no difference between the groups in CES-D total score at baseline (P = 0.7859). A longitudinal linear mixed model analysis revealed a significant interaction between time of assessment and light condition [F(3,107) = 2.90; P = 0.0386; ɳ

conclusionThese findings demonstrate that PEI using BWL during MM ASCT hospitalization is effective in reducing the development of depression. Future studies should examine the mechanisms whereby PEI improves depression.

Indexed as

Hematopoietic Stem Cell TransplantationLightingDepressionFemaleHumansMaleMultiple MyelomaRisk FactorsSeverity of Illness IndexTransplantation, AutologousAutologous Stem Cell TransplantBright Light TherapyCircadian RhythmsMultiple Myeloma

Identifiers

PMID30099857
PMCPMC6144249
OpenAlexW2887405213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.